Lp-PLA2 silencing ameliorates inflammation and autophagy in nonalcoholic steatohepatitis through inhibiting the JAK2/STAT3 pathway. This evidence concerns the gene PLA2G7 and metabolic dysfunction-associated steatohepatitis.